Form 4 holding
Chief Operating Officer
Oncology Institute, Inc.
- Security class
- Common stock
- Shares / value
- 242,992
- Estimated value
- $512,713
- Report date
- 17 Mar 2023
- Price
- $2.11
- Ownership
- Direct
Matthew P. Miller - Chief Operating Officer at Starling Oncology, Inc.
Issuer-level insider activity
- Role
- Chief Operating Officer
- Issuer ticker
- STLN, STLNW on Nasdaq, DFPH on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew P. Miller since 27 Sep 2025
Reported holdings for Matthew P. Miller in Starling Oncology, Inc.
Form 4 holding
Chief Operating Officer
Oncology Institute, Inc.
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 169,169
- Estimated value
- Report date
- 17 Mar 2023
- Price
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Transaction history for Matthew P. Miller in Starling Oncology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.